Document Detail

Key factors in the acceptability of treatment as prevention (TasP) in Scotland: a qualitative study with communities affected by HIV.
MedLine Citation:
PMID:  25482649     Owner:  NLM     Status:  Publisher    
OBJECTIVES: There is a clear need to understand the factors that might prevent and/or facilitate the effective use of HIV treatment as prevention (TasP) at an individual level. This paper reports on findings from the first qualitative study in the UK exploring the acceptability of TasP among gay, bisexual and/or men who have sex with men (MSM) and migrant African communities in Scotland.
METHODS: We conducted seven exploratory focus group discussions (FGDs) with convenience samples of MSM (five FGDs, n=22) and mixed-gender African (two FGDs, n=11) participants. Of these, three FGDs were conducted with HIV-positive MSM (n=14) and one FGD with HIV-positive Africans (n=8). We then conducted 34 in-depth interviews (IDIs) with a purposive sample of MSM (n=20) and Africans (n=14, women=10). Half were HIV-positive (MSM, n=10; African, n=7). FGD and IDI data were analysed thematically drawing on predetermined and emergent themes.
RESULTS: We found that inequalities in HIV literacy could be a barrier to TasP, as could social constraints, such as criminalisation of transmission, increased risk of sexually transmitted infection and increased burden of treatment. We also identified psychological barriers such as perceptions of risk. However, relationships and shared decision making were identified as potential facilitators for TasP.
CONCLUSIONS: Our results suggest that potential use and management of TasP may not be straightforward. It could be contingent on reducing inequalities in HIV literacy, minimising the perceived burden of treatment and other potential risks, and addressing the dynamics of existing and socially acceptable risk management strategies, especially in relation to long-term serodiscordant relationships.
I Young; P Flowers; L M McDaid
Related Documents :
19861339 - Treatment of acute hepatitis c in hiv infection.
7513149 - Review of serologic testing for hepatitis c virus infection and risk of posttransfusion...
20981809 - Hepatitis c virus-associated polyarteritis nodosa.
2178279 - Hepatitis c virus infection in intravenous drug users: prevalence and risk factors.
20096149 - Declining hcv seroprevalence in pregnant women with hiv.
21982599 - Determination of hcv genotypes and viral loads in chronic hcv infected patients of haza...
20515419 - Prevalence and factors associated with renal dysfunction among hiv-infected patients.
18499559 - Ards in an hiv-positive patient associated to respiratory syncytial virus.
22311149 - Predicting depression in mothers with and without hiv: the role of social support and f...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-12-7
Journal Detail:
Title:  Sexually transmitted infections     Volume:  -     ISSN:  1472-3263     ISO Abbreviation:  Sex Transm Infect     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-8     Completed Date:  -     Revised Date:  2014-12-9    
Medline Journal Info:
Nlm Unique ID:  9805554     Medline TA:  Sex Transm Infect     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High polymorphism in big defensin gene expression reveals presence-absence gene variability (PAV) in...
Next Document:  What helminth genomes have taught us about parasite evolution.